ANGPTL2 expression in gastric cancer tissues and cells and its biological behavior

Abstract

AIM

To explore expression of angiopoietin-like protein 2 (ANGPTL2) and its effect on biological behavior such as proliferation and invasiveness in gastric cancer.

METHODS

Western blotting was used to detect expression of ANGPTL2 in 60 human normal gastric tissues, 60 human gastric cancer tissues and gastric cell lines including GES-1, N87, SGC7901, BGC823 and PAMC82. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Transwell assay were used to detect the proliferation and invasive ability of gastric cancer cells.

RESULTS

Compared to normal tissues, ANGPTL2 protein levels were significantly upregulated in gastric tissues, and this level was closely correlated with gastric tumor grade, clinical stage and lymph node metastasis. Compared to GES-1 cells, ANGPTL2 mRNA and protein levels were significantly increased in gastric cancer cells including N87, SGC7901, BGC823 and PAMC82. The expression of ANGPTL2 in highly malignant gastric cancer cell lines BGC823 and PAMC82 was significantly higher than in low malignancy gastric cancer cell lines N87 and SGC7901. MTT and Transwell experiments indicated that the proliferation rate and invasive ability of stable overexpressed gastric cancer cells was faster than in cells transfected with Lv-NC and blank control cells, and the invasive ability of stable overexpressed gastric cancer cells was higher than that of cells transfected with Lv-NC and blank control cells.

CONCLUSION

ANGPTL2 contributed to proliferation and invasion of gastric cancer cells. In clinical treatment, ANGPTL2 may become a new target for treatment of gastric cancer.

Key Words: Gastric cancer; Angiopoietin-like protein 2; Cell invasion; Cell proliferation

Core tip: Expression of angiopoietin-like protein 2 (ANGPTL2) was significantly elevated in gastric cancer tissues and cells. The higher the level of malignancy of the cancer, the higher the expression of ANGPTL2 became. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and Transwell assays estimated that the proliferative and invasive ability of lentivirus-infected gastric cancer cells were evidently improved compared to the Lv-NC and blank control groups, which indicate that ANGPTL2 was conducive to the proliferation and invasion of gastric cancer cells.

INTRODUCTION

Cancer has a high morbidity and mortality[1-4]. In China, with the improvement of the economy and the enormous change in lifestyle and eating habits, the morbidity and mortality of gastric cancer have increased annually. In addition, the progression of this disease has become complex. Latest research has found that angiopoietin-like protein 2 (ANGPTL2) is highly expressed in human tissues of the intestine, fat, retina and heart. Furthermore, more research related to the significant high expression of ANGPTL2 in pulmonary cancer tissues, as well as distant metastasis in lung tissues and lymph nodes, has emerged, indicating that ANGPTL2 promotes pulmonary cancer cell proliferation and invasion[5-12]. The study of Teicher[13] also estimated its high expression in soft tissue sarcomas, implicating that ANGPTL2 may accelerate the progression of soft tissue sarcomas. In addition, some studies have reported high expression of ANGPTL2 in various malignant tumors, illustrating that ANGPTL2 is likely to enhance the proliferative and invasive ability of these tumor cells[14-18]. Despite the intimate connection between ANGPTL2 and multiple malignant tumors, there are few studies of its expression level and proliferative and invasive ability in gastric cancer, suggesting a need for further in-depth studies.

Our principle aims in the present study were to investigate the expression level of ANGPTL2 in gastric cancer and normal stomach, and determine its effect in gastric cancer cell proliferation and invasion through western blotting and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Transwell assays. This could help to provide a novel target for better gastric cancer therapy.

MATERIALS AND METHODS

Materials

Sixty patients diagnosed and confirmed with gastric cancer in Zhongshan Hospital in Shanghai from December 2012 to January 2015 were enrolled in the present study. Patients’ age ranged between 25 and 80 years, with a median age of 51 years. Tumor tissues and normal adjacent cancer tissues were gathered and designated as the experimental and control groups, respectively. Informed consent from patients’ family members and approval from the Ethics Committee of the institution were obtained before the tissues were collected as experimental specimens. In addition, GES-1, N87, SGC7901, BGC823 and PAMC82 cells were all provided by the China Typical Culture Preservation Center.

Western blotting

Total protein was extracted from cell lysates (with protease inhibitors) and protein concentration was measured by the Bradford method. Polyacrylamide gel was prepared by placing in a sufficient running buffer. Then, protein samples were loaded based on the concentration measured before. Electrophoresis was started at 50 V, and adjusted to 100 V when the samples were entered into the separation gel. After electrophoresis was over, all samples were transferred onto a PVDF membrane. The membrane was incubated with blocking buffer for 2 h, followed by primary antibody incubation overnight at 4 °C on a rotator. The next day, the primary antibody was discarded and the membrane was washed three times. The membrane was incubated with a secondary antibody for 1 h at room temperature, and was washed three times after that. Finally, exposure was performed and data was analyzed in detail.

Lentivirus infection

PAMC82 gastric cancer cells were collected and seeded onto six-well plates with a standard 10⁵/mL cell suspension density at 2 mL/well, followed by lentivirus infection after 2 h. Cells were divided into the ANGPTL2 overexpression group (Lv-ANGPTL2), ANGPTL2 interference group (Lv-ANGPTL2-shRNA) and control group (Lv-NC). Ultimately, uninfected cells were removed through screening.

MTT assay

The PAMC82 gastric cancer cell suspension was seeded into 96-well plates, keeping it within 5000 cells and 100 μL of cell suspension per well, and cultured in an incubator. This included three replicates for each group, and four 96-well plates were used in total. A 20-μL MTT solution was added into the plates on days 1, 2, 3 and 4. Then, cells were incubated for 4 h, the culture solution was discarded, and DMSO solution was added. Absorbance value was measured after 10 min.

Transwell assay

PAMC82 gastric cancer cell strains were divided into three groups: Lv-ANGPTL2, Lv-ANGPTL2-shRNA and Lv-NC groups. Afterwards, 300 μL of cells at 10⁶/mL density were plated into the invasive chamber, cultured in an incubator for 1 d, and OD value was detected.

Statistical analysis

SPSS version 17.0 software was used to analyze all data. Gray and OD values of ANGPTL2 and β-actin protein were expressed as mean ± SD. Comparisons of ANGPTL2 protein gray values between high-medium and poor tumor differentiation, T1 + T2 and T3 + T4, and lymph node metastasis and non-lymph node metastasis groups were implemented by t test. t test was also performed on gray and OD values of Lv-ANGPTL2, which were compared with Lv-NC and the blank control group; while Lv-ANGPTL2-shRNA was compared with Lv-NC-shRNA and the blank control group.

RESULTS

Relationship between expression of ANGPTL2 and clinical parameters

Through western blot analysis, gray values of ANGPTL2 in tumor adjacent tissues and gastric cancer tissues were 0.680 ± 0.110 and 0.058 ± 0.009, respectively. Compared to tumor adjacent tissues, the expression of ANGPTL2 in gastric cancer tissues was markedly elevated, and the difference was significant (t = 43.654, P = 0.000). Furthermore, the expression level of ANGPTL2 was closely related to the differentiation of gastric cancer, lymph node metastasis and T stage. The higher the malignant level, the greater the expression of ANGPTL2 (Table 1).

Table 1 Association of ANGPTL2 expression with pathological features.

Group		n	Gray value of ANGPTL2	T value	P value
Tumor differentiation	High-medium differentiation	17	0.500 ± 0.221	-4.770	0
	Low differentiation	43	0.821 ± 0.240
T stage	T1 + T2	22	0.402 ± 0.198	-5.907	0
	T3 + T4	38	0.803 ± 0.280
Lymph node metastasis	Metastatic	35	0.680 ± 0.210	5.591	0
	Non-metastatic	25	0.404 ± 0.153

ANGPTL2: Angiopoietin-like protein 2.

ANGPTL2 protein levels by Western blot assay

The difference in protein expression was analyzed in normal gastric cell strain GES-1 and the four gastric cancer cells (N87, SGC7901, BGC823 and PAMC82) by western blotting. The protein expression level of ANGPTL2 in the four cancer cells (N87, SGC7901, BGC823 and PAMC82) was 1.1-, 1.3-, 1.8- and 2.1-fold, respectively, compared to the normal human gastric cell strain. ANGPTL2 protein expression levels in the four gastric cancer cell strains were significantly higher than in the normal gastric cell strain GES-1 (P < 0.05). In addition, β-actin protein expression level in the five cell strains was consistent, showing no significant difference (Figure 1).

Figure 1 Western blot detected the protein expression of ANGPTL2 in gastric cell lines. ANGPTL2: Angiopoietin-like protein 2.

Detection of ANGPTL2 overexpression and knockdown level in gastric cancer strains

To investigate the function of ANGPTL2 in gastric cancer cell proliferation, we overexpressed ANGPTL2 in the PAMC82 gastric cancer cell strain through lentivirus infection. Lv-ANGPTL2, Lv-NC, Lv-ANGPTL2-shRNA and Lv-NC-shRNA (four vectors) were constructed to infect the PAMC82 gastric cancer cell strain. ANGPTL2 levels in the above-mentioned cells and two blank control cells were collected and analyzed using western blotting. ANGPTL2 protein level in the Lv-ANGPTL2-infected PAMC82 gastric cancer cell strain was significantly higher than in Lv-NC infected and blank control cells. Protein levels in the infected Lv-ANGPTL2-shRNA PAMC82 gastric cancer cell strain were significantly lower than in the Lv-NC-shRNA and control cell strains. The inner reference protein β-actin had no obvious change (Tables 2 and 3).

Table 2 Comparison of the gray value of ANGPTL2 protein in blank control, Lv-NC and Lv-ANGPTL2 PAMC82 gastric cancer cells.

Group	ANGPTL2/β-actin
Blank control	0.53 ± 0.02
Lv-NC	0.55 ± 0.02
Lv-ANGPTL2	0.90 ± 0.03a

Compared to the blank control and Lv-NC groups,

^aP < 0.05, n = 3. ANGPTL2: Angiopoietin-like protein 2.

Table 3 Comparison of the gray value of ANGPTL2 protein in blank control, Lv-NC-shRNA and Lv-ANGPTL2-shRNA PAMC82 gastric cancer cells.

Group	ANGPTL2/β-actin
Blank control	0.99 ± 0.04
Lv-NC-shRNA	0.95 ± 0.02
Lv-ANGPTL2-shRNA	0.49 ± 0.03a

Compared to the blank control and Lv-NC-shRNA groups,

^aP < 0.05, n = 3. ANGPTL2: Angiopoietin-like protein 2.

ANGPTL2 elevated the proliferative ability of gastric cancer cells

MTT assay was performed to detect the effect of the proliferative ability of PAMC82 gastric cancer cell strains with overexpression and knockdown of ANGPTL2 levels. There was a similar rising tendency without apparent difference at 4 d in the Lv-NC and Lv-NC-shRNA groups, compared to the blank control group. Nevertheless, on days 2-4, cell proliferative ability in the Lv-ANGPTL2 group was evidently higher than in the Lv-NC and blank control groups, and this was significantly lower in the Lv-ANGPTL2-shRNA group (Figures 2 and 3).

Figure 2 Stable overexpression of ANGPTL2 contributed to proliferation of gastric cancer cells. ^aP < 0.05 vs the control group and Lv-NC group. ANGPTL2: Angiopoietin-like protein 2.

Figure 3 Knockdown of ANGPTL2 weakened the proliferation of gastric cancer cells. ^aP < 0.05 vs the control group and Lv-NC-shRNA group. ANGPTL2: Angiopoietin-like protein 2.

ANGPTL2 improved the invasive ability of gastric cancer cell strains

Transwell assay was performed to detect the role of ANGPTL2 in PAMC82 gastric cancer cell strain invasion. Results indicate that cell invasive ability in the Lv-ANGPTL2 group was significantly higher than in the Lv-NC and blank control groups. In contrast, invasive ability in the Lv-ANGPTL2-shRNA group was significantly lower compared to the Lv-NC-shRNA and blank control groups (Tables 4 and 5).

Table 4 Stable overexpression of ANGPTL2 contributed to the invasive ability of PAMC82 gastric cancer cells.

Group	OD
Blank control	0.279 ± 0.020
Lv-NC	0.281 ± 0.019
Lv-ANGPTL2	0.451 ± 0.008b

Compared to the blank control and Lv-NC groups,

^bP < 0.01, n = 3. ANGPTL2: Angiopoietin-like protein 2.

Table 5 Knockdown of ANGPTL2 weakened the invasive ability of PAMC82 gastric cancer cells.

Group	OD
Blank control	0.301 ± 0.021
Lv-NC-shRNA	0.299 ± 0.013
Lv-ANGPTL2-shRNA	0.156 ± 0.018b

Compared to the blank control and Lv-NC-shRNA groups,

^bP < 0.01, n = 3. ANGPTL2: Angiopoietin-like protein 2.

DISCUSSION

The morbidity of gastric cancer has increased with economic development and changes in dietary patterns[19-22]. Furthermore, Helicobacter pylori infection, gastric polyps, and gastritis can lead to gastric cancer[23-27]. Recently, Kadomatsu et al[28] found a novel secreted glycoprotein, ANGPTL, which is highly expressed in adult hearts, as well as in fatty tissues. This protein has a similar function as angiopoietin, which probably regulates vascular endothelial cell function and migration, and angiogenesis. Research has shown that the overexpression of ANGPTL2 in fatty tissues in mice might result in inflammation and invasion of macrophages. Furthermore, the expression of interleukin (IL)-1, IL-6 and tumor necrosis factor inflammation factors in fatty tissues was evidently higher than in wild-type mice[29-31]. Even though we are aware of ANGPTL2, its expression level in gastric cancer and its effects on gastric cancer cell proliferative and invasive ability remain unclear. Hence, our purpose in the present study was to explore the difference in expression level of ANGPTL2 between gastric cancer and normal stomach, as well as its impact on gastric cancer cell proliferation and invasion, thereby providing a novel target for better gastric cancer therapy.

The present study indicates that ANGPTL2 protein level in gastric cancer tissues significantly increased compared to normal stomach tissues, which was also closely related to tumor differentiation, T stages and lymph node metastasis. Gastric cancer cells with poor differentiation had higher ANGPTL2 protein levels; protein levels in T3 + T4 gastric cancer revealed a higher degree than in T1 + T2 gastric cancer; and ANGPTL2 protein expression levels in gastric cancer with lymph node metastasis was significantly higher compared to that in non-metastatic cancer; estimating that ANGPTL2 might accelerate the incidence of gastric cancer. Research has shown that a lifetime after pulmonary cancer operation is negatively correlated with ANGPTL2 expression in pulmonary tissues, and ANGPTL2 expression level in pulmonary cancer cells could accelerate the invasion and metastasis of cells through autocrine and paracrine mechanisms[5,6]. The high expression of ANGPTL2 in gastric cancer probably exerted similar effects as the pulmonary tumor, accelerating gastric cancer cell invasion and metastasis, as well as the incidence and progression of gastric cancer.

Next, western blotting was performed to analyze the protein expression of ANGPTL2 at the translational level. ANGPTL2 protein expression was higher in gastric cancer cell strains BGC823 and PAMC82, and was 1.8- and 2.1-fold compared to that in normal gastric cell strains. As for the two other gastric cancer cell strains, N87 and SGC7901 cells had elevated ANGPTL2 protein expression levels that were slightly lower compared to normal levels. The probable explanation is that the N87 and SGC7901 cell lines had a lower metastatic capacity and the BGC823 and PAMC82 cell lines had a higher degree of malignancy, which exhibited strong migratory ability[32-34]. Recent studies have reported that the carcinogenic capacity of PAMC82 cells is higher than that of N87 cells[35,36]. In addition, compared to the N87 and SGC7901 cell lines, ANGPTL2 protein expression in the BGC823 and PAMC82 cell lines was higher, demonstrating that ANGPTL2 expression was greater in gastric cancer cells with a higher degree of malignancy.

The present study used PAMC82 cells that belonged to poorly differentiated gastric carcinoma cell strains, which strengthened gastric cancer proliferation and invasion studies[37]. Due to the higher efficiency of the lentivirus infection, we used the lentivirus infection to interfere with and overexpress ANGPTL2 protein[38]. The overexpression and knockdown of ANGPTL2 protein was satisfactory, with the confirmation of western blot for the sequential study.

MTT and Transwell assays demonstrated that ANGPTL2 accelerated gastric cancer cell strain PAMC82 propagation and invasion, but interference with ANGPTL2 expression obviously blocked this phenomenon reversibly. The above findings suggested that ANGPTL2 contributed to gastric cancer cell strain proliferation and migration. Gao et al[39] found that ANGPTL2 inhibited apoptosis by disturbing the tumor intracellular signaling pathway, which accelerated cell growth and facilitated invasion. Other studies have indicated that ANGPTL2 can enhance the activity of the Rec-1/NF-кB pathway, promoting angiogenesis and facilitating the migration of THP-1 by conjugation with integrin[40], and playing a critical role in tumor proliferation and invasion[41-43]. As a consequence, we hypothesize that ANGPTL2 is likely to reduce apoptosis through conjugation with integrin, which facilitates the expression of certain proteins, and activates the corresponding pathway to accelerate gastric cancer cell invasion and migration. However, ANGPTL2 probably promotes gastric cancer cell invasion and migration through other approaches as well, which need to be further explored.

Although there were limitations to this study, such as the small number of samples, it was successful in general. In conclusion, ANGPTL2 protein expression levels were higher in gastric cancer tissues compared to tumor adjacent tissues. ANGPTL2 protein expression levels in gastric cancer cell strains were significantly higher than in normal gastric epithelial cell strains. Furthermore, the higher the degree of malignancy of gastric cancer tissues and cell strains, the higher the expression level of ANGPTL2 became. Moreover, ANGPTL2 contributed to gastric cancer cell strain propagation and migration, which may be used as a novel target for the treatment of human gastric cancer. To understand further the function of ANGPTL2 in gastric cancer occurrence and progression, we need to conduct further in-depth studies on the role of ANGPTL2 upstream regulating factors, to provide a new target for gastric cancer therapy.

COMMENTS

Background

In China, with the improvement of the economy and the enormous change in lifestyle and eating habits, the morbidity and mortality of gastric cancer has increased annually. In addition, the progression of this disease is complex.

Research frontiers

This latest research found that angiopoietin-like protein 2 (ANGPTL2) was highly expressed in human tissues in the intestine, fat, retina and heart. Furthermore, more research related to the high expression of ANGPTL2 in pulmonary cancer tissues, as well as in distant metastasis to lung tissues and lymph nodes, has emerged, indicating that ANGPTL2 promotes pulmonary cancer cell proliferation and invasion. Teicher et al also estimated its high expression in soft tissue sarcoma, implicating that ANGPTL2 might accelerate the progression of soft tissue sarcoma. In addition, some studies have reported high expression of ANGPTL2 in various malignant tumors, illustrating that ANGPTL2 is likely to increase the proliferative and invasive ability of these tumor cells. Despite the intimate connection between ANGPTL2 and multiple malignant tumors, there were few studies on its expression level and proliferative and invasive ability in gastric cancers, suggesting the need for further in-depth studies.

Innovations and breakthroughs

ANGPTL2 protein expression level in gastric cancer tissues and cell strains was significantly higher. The higher the degree of malignancy of the tumor, the higher the expression level of ANGPTL2 protein. ANGPTL2 contributed to the proliferation and invasion of gastric cancer cells. In clinical treatment, ANGPTL2 may become a new target for the treatment of gastric cancer.

Applications

Compared to tumor adjacent tissues, ANGPTL2 protein expression levels were higher in gastric cancer tissues. ANGPTL2 protein expression levels in gastric cancer cell strains were significantly higher than in normal gastric epithelial cell strains. The higher the degree of malignancy of gastric cancer tissues and cell strains, the higher the expression level of ANGPTL2. In addition, ANGPTL2 contributed to gastric cancer cell strain propagation and migration, which may be used as a novel target for the treatment of human gastric cancer.

Peer-review

This is an interesting manuscript about the ANGPTL2 expression in gastric cancer tissues and cells.